Skip to main content
. 2024 Mar 6;15:1335246. doi: 10.3389/fphar.2024.1335246

FIGURE 3.

FIGURE 3

Selection criteria for compound validation. Summary of selection criteria applied to prioritize compounds for validation from ADM inhibition (wildtype mice organoids) and ADM reversal (Cre-mice organoids) screens. Cytotoxicity was evaluated by calcein AM staining. Compounds that overlapped in all three selection criteria (apicidin and chaetocin in ADM inhibition assay; chaetocin in ADM reversal assay) are shown in red and were prioritized for validation in dose response.